Cidara Therapeutics, Inc. revenue for the last year amounted to 57.90 M EUR, the most of which — 57.90 M EUR — came from its highest performing source at the moment, Antifungal and Antiviral Drugs, the year earlier bringing 60.07 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Cidara Therapeutics, Inc. 57.90 M EUR, and the year before that — 60.07 M EUR.